PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
32157879-3	2020	The objective of the current study was to explore the effects of LRW on vascular stress in vascular smooth muscle cells (VSMCs) under angiotensin II (Ang II)-induced cellular stress.	3-(Trifluoromethyl)cinnamic acid	65-68	angiotensinogen	Rattus norvegicus	134-148
32157879-3	2020	The objective of the current study was to explore the effects of LRW on vascular stress in vascular smooth muscle cells (VSMCs) under angiotensin II (Ang II)-induced cellular stress.	3-(Trifluoromethyl)cinnamic acid	65-68	angiotensinogen	Rattus norvegicus	150-156
32157879-4	2020	LRW treatment could decrease Ang II-triggered superoxide production, inflammation, and proliferation in VSMCs.	3-(Trifluoromethyl)cinnamic acid	0-3	angiotensinogen	Rattus norvegicus	29-35
16717437-1	2006	Leucinyl-arginyl-tryptophan (LRW) is a new peptide inhibitor of the angiotensin converting enzyme (ACE) that was previously predicted through quantitative structure-activity relationship modeling.	3-(Trifluoromethyl)cinnamic acid	29-32	angiotensin I converting enzyme	Homo sapiens	68-97
16717437-1	2006	Leucinyl-arginyl-tryptophan (LRW) is a new peptide inhibitor of the angiotensin converting enzyme (ACE) that was previously predicted through quantitative structure-activity relationship modeling.	3-(Trifluoromethyl)cinnamic acid	29-32	angiotensin I converting enzyme	Homo sapiens	99-102